drugset / Trial / NCT00030693

Vaccine Therapy in Treating Patients With Metastatic Solid Tumors

NCT00030693

Phase 1 Terminated 42 enrolled National Cancer Institute (NCI)
RandomizedParallel-groupOpen-labelTreatment

Summary

Randomized phase I trial to compare the effectiveness of two different vaccines given directly into the tumor in treating patients who have metastatic solid tumors. Vaccines may make the body build an immune response to kill tumor cells. Infusing the vaccine directly into a tumor may cause a stronger immune response and kill more tumor cells. It is not yet known which vaccine may be more effective in treating metastatic solid tumors

Timeline

Start
2001-12
Primary completion
2010-04
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject recombinant fowlpox-B7.1 vaccine Vaccine Other
Subject recombinant fowlpox-TRICOM vaccine Vaccine Other